MWABA CHISELA: Open Payments
NPI 1710631593 · ACWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 24 payments from 8 companies in 2025. Trend: 2023 $216 · 2024 $703 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $232 |
| ABBVIE INC. | 6 | $140 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| Janssen Biotech, Inc. | 4 | $85 |
| GENZYME CORPORATION | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| QOL Medical, LLC | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, SKYRIZI, MAVYRET, Sucraid, EOHILIA, CREON.
Industry payments across GA — which companies pay providers there.
